Acalabrutinib
Update Venetoclax in CLL
Obinutuzumab
(Update) Acalabrutinib in CLL and MCL
Zanubrutinib
Leukemia & Lymphoma Society
NCCN COVID-19 Resources Page
UpToDate
JADPRO Roundtable Series: Best Practices in the Use of BTK Inhibitors in CLL